NCT07204847View on ClinicalTrials.gov

Prognostic Impact of Guideline-recommended Timing for Invasive Strategy in NSTEMI

CompletedOBSERVATIONAL
Enrollment

407

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

May 1, 2025

Study Completion Date

June 20, 2025

Conditions
NSTEMINSTE-ACS (NSTEMI and UA)NSTEMI - Non-ST-Segment Elevation Myocardial Infarction
Trial Locations (1)

34000

CHU de Montpellier, Montpellier

All Listed Sponsors
collaborator

University Hospital, Nīmes

UNKNOWN

lead

University Hospital, Montpellier

OTHER

NCT07204847 - Prognostic Impact of Guideline-recommended Timing for Invasive Strategy in NSTEMI | Biotech Hunter | Biotech Hunter